Abstract Library

#3032 Lung Side and Site: The Importance of Location and the Prognostic Implication in Lung Neuroendocrine Tumors

Introduction: Lung neuroendocrine tumors (NET) are classified as typical (TC) and atypical carcinoids (AT), according to their mitotic count and the presence of necrosis. However, a role for tumor side (right vs left) and location (central vs peripheric) has not been established so far.

Conference: 17th Annual ENETSConcerence (2020)

Presenting Author: La Salvia A

Authors: La Salvia A, Trevisi E, Brizzi M, Espinosa Olarte P, Enguita A,

Keywords: Lung neuroendocrine tumors, tumor side (left versus right), tumor site (peripheric versus central), prognostic factors, survival,

#2733 Pancreatic Metastases Originating from Intestinal Neuroendocrine Tumours

Introduction: Pancreatic metastases are rare, accounting for 1 to 2% of pancreatic tumours. Data on pancreatic metastases of intestinal NETs are lacking.

Conference: 17th Annual ENETSConcerence (2020)

Presenting Author:

Authors: Sadeh A, Librizzi D, Figiel J, Rodepeter F, Denzer U,

Keywords: Ki-67, prognosis, endoscopic ultrasound, intestinal NET, pancreatic metastases,

#2260 Carcinoid Heart Failure in a Metastatic Duodenal Neuroendocrine Tumor: A Challenging Case Report.

Introduction: Carcinoid heart disease (CHD) is a potenzial fatal cardiac manifestation, characterized by fibrous endocardial thickening involving right-sided heart valves. In 70% of cases, CHD occurs in advanced small bowel NETs with carcinoid syndrome (CS). Serotonin seems to play a main role. Early recognition and surgical intervention may improve the outcome of patients.

Conference: 15th Annual ENETSConcerence (2018)

Presenting Author: Brizzi M

Authors: Brizzi M, La Salvia A, Parisi F, Scagliotti G,

Keywords: Carcinoid Hearth Disease, Carcinoid syndrome, Surgery, somatostatin analogues,

#1578 Everolimus Cumulative Dose and Dose Intensity in Pancreatic Neuroendocrine Tumors

Introduction: Everolimus represents a new treatment option for advanced pancreatic neuroendocrine tumors (pNETs).

Conference: 13th Annual ENETSConcerence (2016)

Presenting Author: Berardi R

Authors: Berardi R, Torniai M, Pusceddu S, Spada F, Brizzi M,

Keywords: pNET, dose intensity, targeted therapy, everolimus, cumulative dose,

#1480 Systemic Treatment Sequences across Europe for Patients (pts) with Advanced Non-functional (NF) Well-Differentiated Pancreatic Neuroendocrine Tumours (WD pNETs)

Introduction: Different systemic therapies (ST) are available for pts with advanced WD pNETs; however, the best treatment modalities and optimal sequencing are currently unknown.

Conference: 13th Annual ENETSConcerence (2016)

Presenting Author: Custodio A

Authors: Custodio A, Van Adrichem R, Brizzi M, Heetfeld M, Jimenez-Fonseca P,

Keywords: pNET, treatment sequences,